VYNE Therapeutics, Inc. (VYNE)
0.4039
+0.03
(+7.19%)
USD |
NASDAQ |
Dec 10, 16:00
0.4065
0.00 (0.00%)
After-Hours: 19:02
VYNE Therapeutics Total Assets (Quarterly): 36.13M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Theravance Biopharma, Inc. | 415.46M |
| NovaBay Pharmaceuticals, Inc. | 3.487M |
| Palatin Technologies, Inc. | 8.615M |
| Theriva Biologics, Inc. | 30.84M |
| Oragenics, Inc. | 12.71M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.044M |
| Shareholders Equity (Quarterly) | 32.09M |
| Current Ratio | 8.874 |
| Net Debt Paydown Yield | 0.27% |